Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS ®) Mouthpiece and Controller
Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) -- -- Proceeds from recent stock issuances through the Company’s At-The-Market (“ATM”) program extends cash runway into the third quarter 2024 --…#atm #newtown #helius #cms #healthcare #levelii #neuromodulation #ponstherapy #daneandreeff #ponsdevice (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2024 Category: Consumer Health News Source Type: news
Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions
(MedPage Today) -- WEST PALM BEACH, Fla. -- Paramagnetic rim lesions (PRLs) predicted cognitive decline in multiple sclerosis (MS), data from a longitudinal cohort study showed.
At year 4, scores on the Symbol Digit Modalities Test (SDMT), a... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 4, 2024 Category: Neurology Source Type: news
Fear of falling and common symptoms of multiple sclerosis: physical function, cognition, fatigue, depression, and sleep - a systematic review - Abou L, Peters J, Freire B, Sosnoff JJ.
BACKGROUND: Fear of falling (FOF) is a common concern among persons with multiple sclerosis (MS) and affects the performance of their daily living activities. Falls may result in FOF, leading to worsening of symptoms of MS, physical deconditioning, and exp... (Source: SafetyLit)
Source: SafetyLit - March 4, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Ozanimod Controls MS Disease Activity Regardless of Age
(MedPage Today) -- WEST PALM BEACH, Fla. -- Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 4, 2024 Category: Neurology Source Type: news
Long COVID May Be Difficult to Identify in MS
(MedPage Today) -- WEST PALM BEACH, Fla. – People with multiple sclerosis (MS) appeared to have a low risk of developing long COVID, but lingering complaints after SARS-CoV-2 infection were difficult to untangle from MS symptoms, registry... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 3, 2024 Category: Infectious Diseases Source Type: news
Obesity Associated With Faster MS Disease Progression
(MedPage Today) -- WEST PALM BEACH, Fla. -- Obesity in multiple sclerosis (MS) was tied to faster worsening of disability and an increased risk of physical, psychological, and cognitive decline, a prospective cohort study showed.
Compared with... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 2, 2024 Category: Neurology Source Type: news
Philips spotlights AI, image-guided therapy, and CT at ECR 2024
VIENNA – Philips brought a clutch of new products to ECR 2024, including two image-guided therapy systems and a new CT scanner.
In the image-guided therapy section of its booth, the company unveiled its Azurion neuro biplane system. Designed to support diagnosis, image guidance, and therapy assessment of neurovascular patients, Azurion neuro biplane integrates images from two x-ray detectors into a 3D view and can serve as a complete interventional system, according to the vendor.
The system includes Philips’ latest Neuro Suite software and services, its ClarityIQ image processing software, and neuro-specific tools, ...
Source: AuntMinnie.com Headlines - March 2, 2024 Category: Radiology Authors: Erik L. Ridley Tags: Imaging Informatics Advanced Visualization Source Type: news
Roche Pharma launches multiple sclerosis treatment drug in India
The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news
A Step Toward Wellness: The Benefits of Early Rehab in MS A Step Toward Wellness: The Benefits of Early Rehab in MS
Patricia Bobryk and Colleen Harris discuss the importance of starting comprehensive rehabilitation early in multiple sclerosis care.Consortium of Multiple Sclerosis Centers (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 27, 2024 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Improved Communication Center Stage in Multiple Sclerosis Improved Communication Center Stage in Multiple Sclerosis
In this Care Cues, a neurologist and a stand-up comic with multiple sclerosis share thoughts on improving communication between clinicians and patients at diagnosis and throughout treatment.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2024 Category: Consumer Health News Tags: None Care Cues Source Type: news
Effect of explicit prioritization on dual-tasks during standing and walking in people with neurological and neurocognitive disorders: a systematic review and meta-analysis - Criekinge TV, Sahu U, Bhatt T.
OBJECTIVES: To examine the effectiveness of explicit task (i.e., equal, motor or cognitive) prioritization during dual tasking (DT) in adults with neurological and neurocognitive disorders (Stroke, Parkinson's disease, Multiple Sclerosis, Dementia, Alzheim... (Source: SafetyLit)
Source: SafetyLit - February 26, 2024 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
UK Charity Admits It Was Wrong To Fire Life-Long Volunteer Over Pronouns
Authored by Steve Watson via Modernity.news, The National Multiple Sclerosis Society has done a 180 and apologised for telling a 90-year-old volunteer she was not welcome anymore because she had violated diversity guidelines…#stevewatson #franitkoff #mrsitkoff #mssociety #fran #libsoftiktok #alphabetequity #xmodernitynews (Source: Reuters: Health)
Source: Reuters: Health - February 25, 2024 Category: Consumer Health News Source Type: news
First-Line Highly Effective Therapy Better for Pediatric MS First-Line Highly Effective Therapy Better for Pediatric MS
New research supports the use of highly effective therapies as first-line treatment in children with relapsing-remitting pediatric-onset multiple sclerosis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 22, 2024 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: a multicentre randomised controlled trial - Hoang P, Sturnieks DL, Butler A, Chaplin C, Hicks C, Lo J, Ratanapongleka M, Robinson S, Smith N, Turner J, Krishnan AV, Barnett M, Gandevia S, Lord SR, Menant JC.
BACKGROUND: Cognitive-motor step training can improve stepping, balance and mobility in people with multiple sclerosis (MS), but effectiveness in preventing falls has not been demonstrated. OBJECTIVES: This multisite randomised controlled trial aim... (Source: SafetyLit)
Source: SafetyLit - February 19, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Risk
(MedPage Today) -- Compared with moderately effective therapies, initial use of highly effective therapies for pediatric-onset multiple sclerosis (MS) was associated with a reduced risk of relapse, a retrospective cohort study suggested.
Among... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 17, 2024 Category: Neurology Source Type: news
